miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.

miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.
复制标题

miR-192-5p通过SCD-1调节非酒精性脂肪肝中的脂质合成

DOI:
10.3748/wjg.v23.i46.8140
复制
发表时间:
2017-12-14
影响因子:
4.3
通讯作者:
Fan JG
Fan JG
中科院分区:
医学2区
文献类型:
--
作者:
Liu XL;Cao HX;Wang BC;Xin FZ;Zhang RN;Zhou D;Yang RX;Zhao ZH;Pan Q;Fan JG

文献摘要

参考文献

被引文献

相似文献

目的评估非酒精性脂肪性肝病(NAFLD)模型中miR-192-5p的水平,并证明miR-192-5p在脂质积累中的作用。方法30只Sprague Dawley大鼠随机分为3组,分别饲喂标准日粮、高脂日粮和注射利拉鲁肽的高脂日粮。在16周结束时,测量肝脏miR-192-5p和硬脂酰辅酶a去饱和酶1 (SCD-1)水平。将MiR-192-5p模拟物和抑制剂以及SCD-1 siRNA转染到暴露于棕榈酸(PA)的Huh7细胞中。脂质积累通过油红O染色和甘油三酯测定来评估。双荧光素酶报告基因测定证实了直接相互作用。结果HFD大鼠肝脏miR-192-5p和SCD-1蛋白水平分别较对照组降低0.46倍和升高3.5倍,经利拉鲁肽注射液缓解后可逆转(P < 0.01)。暴露于PA的Huh7细胞miR-192-5p和SCD-1蛋白水平也分别下调和上调(P < 0.01)。在Huh7细胞中转染miR-192-5p模拟物和抑制剂分别可显著抑制和促进SCD-1蛋白水平(P < 0.01)。在野生型SCD-1中,miR-192-5p模拟物和miR-192-5p抑制剂分别抑制和增强荧光素酶活性(P < 0.01),而在突变型SCD-1中无明显作用。在pa处理的Huh7细胞中,过表达MiR-192-5p可显著降低脂质积累,转染SCD-1 siRNA可消除MiR-192-5p抑制剂加重的脂质沉积(P < 0.01)。结论本研究表明miR-192-5p在脂质合成中具有负调控作用,其直接调控SCD-1介导脂质合成。
AIM To evaluate the levels of miR-192-5p in non-alcoholic fatty liver disease (NAFLD) models and demonstrate the role of miR-192-5p in lipid accumulation. METHODS Thirty Sprague Dawley rats were randomly divided into three groups, which were given a standard diet, a high-fat diet (HFD), and an HFD with injection of liraglutide. At the end of 16 weeks, hepatic miR-192-5p and stearoyl-CoA desaturase 1 (SCD-1) levels were measured. MiR-192-5p mimic and inhibitor and SCD-1 siRNA were transfected into Huh7 cells exposed to palmitic acid (PA). Lipid accumulation was evaluated by oil red O staining and triglyceride assays. Direct interaction was validated by dual-luciferase reporter gene assays. RESULTS The HFD rats showed a 0.46-fold decrease and a 3.5-fold increase in hepatic miR-192-5p and SCD-1 protein levels compared with controls, respectively, which could be reversed after disease remission by liraglutide injection (P < 0.01). The Huh7 cells exposed to PA also showed down-regulation and up-regulation of miR-192-5p and SCD-1 protein levels, respectively (P < 0.01). Transfection with miR-192-5p mimic and inhibitor in Huh7 cells induced dramatic repression and promotion of SCD-1 protein levels, respectively (P < 0.01). Luciferase activity was suppressed and enhanced by miR-192-5p mimic and inhibitor, respectively, in wild-type SCD-1 (P < 0.01) but not in mutant SCD-1. MiR-192-5p overexpression reduced lipid accumulation significantly in PA-treated Huh7 cells, and SCD-1 siRNA transfection abrogated the lipid deposition aggravated by miR-192-5p inhibitor (P < 0.01). CONCLUSION This study demonstrates that miR-192-5p has a negative regulatory role in lipid synthesis, which is mediated through its direct regulation of SCD-1.
DOI: 10.1053/j.gastro.2013.11.049
发表时间: 2014-03
期刊: Gastroenterology
影响因子: 29.4
作者:
Lambert JE;Ramos-Roman MA;Browning JD;Parks EJ
通讯作者: Parks EJ
DOI: 10.1016/j.metabol.2015.12.012
发表时间: 2016-08-01
影响因子: 9.8
作者:
Buzzetti, Elena;Pinzani, Massimo;Tsochatzis, Emmanuel A.
通讯作者: Tsochatzis, Emmanuel A.
miR-192的下调通过诱导SREBF1导致肝脏脂肪变性和脂质积累:双酚A引发的非酒精性脂肪肝的新机制
DOI: 10.1016/j.bbalip.2017.05.001
发表时间: 2017-09-01
影响因子: 4.8
作者:
Lin, Yi;Ding, Dongxiao;Dong, Sijun
通讯作者: Dong, Sijun
DOI: 10.1038/onc.2013.478
发表时间: 2014-11-13
期刊: Oncogene
影响因子: 8
作者:
通讯作者: --
DOI: 10.1172/jci44883
发表时间: 2011-04-01
影响因子: 15.9
作者:
Castoldi, Mirco;Spasic, Maja Vujic;Muckenthaler, Martina U.
通讯作者: Muckenthaler, Martina U.